SEC Form 4 · accession 0001140361-17-016607
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darcy G Mott
Officer — Executive VP and CFO
Period of report
Apr 20, 2017
Accepted (ET)
Apr 24, 2017 · 6:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2017 | M | 14,000 | $0.10 | A | 82,000 | D | |
| Common StockF2 | Apr 20, 2017 | S | 10,000 | $43.4447 | D | 72,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $0.10 | Apr 20, 2017 | M | 14,000 | D | — | May 22, 2018 | Common Stock | 14,000 | 0 | D |
| Stock Option (right to buy)F4 | $41.28 | holding | — | — | — | — | Mar 27, 2027 | Common Stock | 19,897 | 19,897 | D |
| Stock Option (right to buy)F3 | $14.00 | holding | — | — | — | — | Jul 30, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy)F3 | $1.25 | holding | — | — | — | — | Aug 8, 2021 | Common Stock | 125,000 | 125,000 | D |
| Stock Option (right to buy)F5 | $25.39 | holding | — | — | — | — | Mar 26, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.09 to $43.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3The option is immediately exercisable.
- F4The option becomes exercisable in three annual installments of 4,974 shares on March 27, 2018, 2019, and 2020 and in one installment of 4,975 shares on March 27, 2021.
- F5The option became exercisable as to 6,250 shares on each of March 26, 2016 and 2017. The remaining shares become exercisable in two equal annual installments of 6,250 shares on March 26, 2018 and 2019.